Nice analogy Ken. Nobody cares about our asses. Th
Post# of 148288
As for giving away doses for the quick results that may speed up an EUA somewhere. I am not opposed to that within reason. The cost of doses are minimal at $75 a dose manufacturing cost. Now that doesn’t factor in our cost of research for covid or any other indication going forward, just bare manufacturing but a reasonable amount of free doses could progress the speed of science. That’s the goal and what is that worth? Call it free advertising when expected results shine and notoriety of a drug that works spreads around the world. It’s like lighting a fuse. Save lives and people notice. People say when you save lives you don’t need to advertise.
Consider it an advertising budget. What’s that worth? 10,000 doses is only $750,000. What is the return on that spent? That’s the question... maybe a smaller amount is being to conservative and shows not enough anecdotal evidence yet again. We can tell and scream about how good Leronlimab is but we need the people that have used it successfully to tell and scream for us.
I say light the fuse... I am optimistic about giving away doses. 400 doses are nothing to me. Give away 10,000 doses and maybe add in some protocols to track and see what happens. It can’t hurt to try a new approach. We need better results some way? Maybe split the doses 5,000 each for Philippines and Brazil. Then see how fast the trials fill up.
How many doses did Remdeathisnear give away? It was a lot. I think it was 40,000 but I am not sure. I should Google it. But someone else can.